Weyergans

Der Vacufit Body Performer hilft aktiv und unterstützend bei Deinem Figur- und Gesundheitstraining, verkürzt die Regenerationszeit und optimiert das körperlichen Gleichgewicht
"Welcome to Weyergans High Care® Medical - your competent partner for intermittent vacuum therapy - IVT."

Current information!
 

Development history

Origin in space medicine

The Intermittent vacuum therapy -IVT- has its technological origin in space medicine. In the absence of gravity (weightlessness), astronauts in space have to undergo a vacuum application every ten hours in a LBNPD (Lower Body Negative Pressure Device) to avoid orthostatic complications; this is the only way to ensure adequate blood circulation in the periphery. The further development of the LBNPD

is the VACUMED® Flow Regeneration System. The device was developed at the Institute for Space Medicine of the German Aerospace Society (DLR). Weyergans High Care AG is research partner and spin-off partner of DLR. The company has invested in pre-clinical and clinical trials and holds patents and approvals. Production takes place in accordance with ISO 13485-2016 at the company's location in Dueren, Rhineland.

Mode of action of Intermittent Vacuum Therapy - IVT -

Like a second external heart
Intermittent vacuum therapy - IVT - alternately applies negative pressure (vacuum) and positive pressure to the lower extremities. This physiologically causes rhythmic vascular dilation and vascular compression, through that naturally provoking the >>flow<< in a purely physical way.

The result: Blood circulation, capillarization and increase in venous and lymphatic reflux. This supports the acceleration of wound healing, extends walking distances, relieves pain and thus decisively improves the quality of the patients' lifes. The treatment is completely painless regardless of the disease.


Please choose:

VACUMED®
VACUMED® A.N.S. QO

Request information material now!

We are happy to help you



Thanks a lot! Your request has been sent!

An error has occurred - please send us one E-Mail.